Analyst Ratings for Mirati Therapeutics (MRTX) [Sells]
MRTX Rating Summary
MRTX Price Target Summary
- Highest: $75.00 (Barclays)
- Lowest: $37.00 (Morgan Stanley)
- Average: $58.36
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$58.36 (-0.6%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Avg. $ Target:
$58.36 (-0.6%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|
